Furthermore, the dense stroma in pancreatic cancer restricts drug penetration through physical barriers while activating cancer-associated fibroblasts (CAFs) to secrete pro-fibrotic factors (e.g., TGF-β1), forming a vicious cycle (5). This evidence concerns the gene TGFB1 and cancer.